DAB2IP and prostate carcinoma: Similarly, upregulation of miR-32 downregulates DAB2IP in prostate cancer, inducing autophagy via mTOR pathway activation and counteracting radiotherapy-induced apoptosis, thus leading to increased cancer cell survival after ionizing radiation treatment [83].